Stock News

3 Surprising Stocks That Have Crushed the Market so Far This Year
2 Compelling Reasons to Buy This Reawakened Pharma Giant
AbbVie, Lilly Atopic Dermatitis Treatments Hit With Further Delays With FDA
AbbVie, Lilly face fresh delays in FDA approval for expanded use of arthritis drugs
Lilly and Incyte provide update on supplemental New Drug Application for baricitinib for the treatment of moderate to severe atopic dermatitis
Lilly and Banner Alzheimer's Institute collaborate on planned Phase 3 prevention trial of donanemab
10 Best Psychedelic Stocks to Buy Now
Eli Lilly buys remaining shares of Protomer Technologies in glucose-responsive insulin play

As seen on...